1 | Wangbi granules | - | - | - | - | 1件: 46 46 |
2 | Wangbi granules simulant | - | - | - | - | 1件: 46 46 |
3 | Warfarin | 1件: Warfarin Warfarin | 1件: D08682
D08682
| 2件: NQO1 NQO1, VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 11件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91 |
4 | Warfarin Potassium | 2件: Potassium Potassium, Warfarin | 2件: D08403
D08403
,
D08682
| 2件: NQO1 NQO1, VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 88 88 |
5 | Warfarin Sodium | 1件: Warfarin Warfarin | 1件: D08682
D08682
| 2件: NQO1 NQO1, VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 49 49 |
6 | Warfarin Sodium Tablets | 1件: Warfarin Warfarin | 1件: D08682
D08682
| 2件: NQO1 NQO1, VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 46 46 |
7 | Warfarin+ Vitamin K | 2件: Phylloquinone Phylloquinone, Warfarin | 1件: D08682
D08682
| 2件: NQO1 NQO1, VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 46 46 |
8 | Water | 1件: Water Water | 1件: D00001
D00001
| - | - | 21件: 2 2, 5, 6, 13, 17, 22, 35, 46, 53, 57, 63, 65, 67, 78, 84, 96, 97, 206, 226, 278, 299 |
9 | WATER FOR INJECTION | 1件: Water Water | 1件: D00001
D00001
| - | - | 1件: 35 35 |
10 | Water for injections | 1件: Water Water | 1件: D00001
D00001
| - | - | 1件: 299 299 |
11 | WATER FOR INJECTIONS, EP | 1件: Water Water | 1件: D00001
D00001
| - | - | 1件: 299 299 |
12 | WAY-130799 | - | - | - | - | 1件: 13 13 |
13 | WAY-177005 | - | - | - | - | 1件: 46 46 |
14 | WD-1603 | - | - | - | - | 1件: 6 6 |
15 | WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
16 | WD-1603 Carbidopa-Levodopa Extended-Release Tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
17 | WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
18 | Weancare-domus | - | - | - | - | 1件: 6 6 |
19 | Wellbutrin (bupropion) | 1件: Bupropion Bupropion | 1件: D07591
D07591
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 96 96 |
20 | WFI | - | - | - | - | 1件: 96 96 |
21 | Whale blubber oil | - | - | - | - | 1件: 46 46 |
22 | Wharton Jelly Mesenchymal stem cells | - | - | - | - | 1件: 97 97 |
23 | Wharton's jelly derived mesenchymal stem cell | - | - | - | - | 1件: 90 90 |
24 | WHARTON’S JELLY DERIVED MESENCHYMAL STEM CELLS | - | - | - | - | 1件: 36 36 |
25 | WHARTON’S JELLY-DERIVED MESENCHYMAL STEM CELLS | - | - | - | - | 1件: 2 2 |
26 | Wheat | 1件: Wheat Wheat | 1件: D06902
D06902
| - | - | 2件: 6 6, 53 |
27 | Wheat bran | 2件: Wheat Wheat, Wheat bran | 1件: D06902
D06902
| - | - | 1件: 6 6 |
28 | Wheat/milk free diet (W/MFD) group | 1件: Wheat Wheat | 1件: D06902
D06902
| - | - | 1件: 53 53 |
29 | Whey protein | - | - | - | - | 2件: 6 6, 96 |
30 | Whey Protein&Prebiotic Supplement | - | - | - | - | 1件: 46 46 |
31 | White chocolate (0% cocoa) | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 |
32 | Whole blood sample | - | - | - | - | 1件: 177 177 |
33 | Whole Exome Sequencing | - | - | - | - | 3件: 65 65, 120, 149 |
34 | Whole genome sequencing | - | - | - | - | 3件: 6 6, 79, 172 |
35 | Whole genomic | - | - | - | - | 1件: 285 285 |
36 | WILATE | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
37 | Wilate 1000 | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
38 | WILATE 1000 I.U. | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
39 | WILATE 450 | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
40 | Wilate 500 | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
41 | WILATE 500 I.U. | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
42 | WILATE 900 | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
43 | WILATE® 450 | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
44 | WILFACTIN | - | - | - | - | 1件: 288 288 |
45 | Willfact | - | - | - | - | 1件: 288 288 |
46 | Wiloctin | - | - | - | - | 1件: 288 288 |
47 | Wilzin | 1件: Zinc Zinc | - | - | - | 1件: 171 171 |
48 | WIN-1001X | - | - | - | - | 1件: 6 6 |
49 | With U-VANCO (vancomycin hydrochloride) | 1件: Vancomycin Vancomycin | 1件: D00212
D00212
| - | - | 1件: 70 70 |
50 | Withania somnifera | - | - | - | - | 1件: 2 2 |
51 | Withhold IS (B cell depletion therapy) | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 |
52 | Withhold IS (MMF or MPA) | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 |
53 | Withhold IS (MTX) | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 |
54 | Without U-VANCO (vancomycin hydrochloride) | 1件: Vancomycin Vancomycin | 1件: D00212
D00212
| - | - | 1件: 70 70 |
55 | WJ-MSCs | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 36 36 |
56 | WM (Shentong Granules) | - | - | - | - | 1件: 66 66 |
57 | Wound topically irrigated with 500mg TXA | - | - | - | - | 1件: 70 70 |
58 | WRAIR_PAM-CF1 | - | - | - | - | 1件: 299 299 |
59 | WTX101 | - | - | - | - | 1件: 171 171 |
60 | Wuling Powder | - | - | - | - | 1件: 6 6 |
61 | WVE-003 | - | - | - | - | 1件: 8 8 |
62 | WVE-004 | - | - | - | - | 2件: 2 2, 127 |
63 | WVE-120101 | - | - | - | - | 1件: 8 8 |
64 | WVE-120102 | - | - | - | - | 1件: 8 8 |
65 | WVE-210201 | - | - | - | - | 1件: 113 113 |
66 | WVE-210201 (suvodirsen) | - | - | - | - | 1件: 113 113 |